Scott Tuten is CMO at Danimer Scientific, Inc. (DNMR). They have made 9 open-market trades across 1 company since 2021, most recently 2023-12-29.
CIK 0001836749
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DNMR | 327,552 | $1.4M |
Shares reported on the most recent Form 4, priced at the 2024-01-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DNMR | SELL · 10b5-1 | 2023-06-20 | 2023-06-20 | $2.74 | $27K | -16.2% | +1.8% | -34.5% |
| DNMR | SELL · 10b5-1 | 2023-05-17 | 2023-05-17 | $3.38 | $34K | -8.3% | -14.2% | -40.8% |
| DNMR | SELL · 10b5-1 | 2023-04-17 | 2023-04-19 | $4.26 | $43K | -24.9% | -18.7% | -26.9% |
| DNMR | SELL · 10b5-1 | 2023-03-17 | 2023-03-21 | $2.10 | $21K | +66.7% | +86.5% | +38.6% |
| DNMR | SELL · 10b5-1 | 2023-02-17 | 2023-02-21 | $2.21 | $22K | +17.1% | -0.9% | +58.3% |
| DNMR | SELL · 10b5-1 | 2023-01-17 | 2023-01-19 | $2.14 | $21K | +6.5% | -1.4% | +87.4% |
| DNMR | SELL · 10b5-1 | 2022-12-19 | 2022-12-21 | $1.63 | $16K | +7.0% | +29.1% | +21.5% |
| DNMR | SELL · 10b5-1 | 2022-11-17 | 2022-11-21 | $2.68 | $27K | -11.1% | -29.6% | -16.6% |
| DNMR | SELL · 10b5-1 | 2022-10-17 | 2022-10-19 | $2.46 | $25K | +15.4% | +14.5% | -1.8% |
| DNMR | SELL · 10b5-1 | 2022-09-19 | 2022-09-21 | $3.58 | $36K | -18.0% | -36.3% | -51.5% |
| DNMR | SELL | 2022-08-17 | 2022-08-18 | $5.06 | $101K | -14.2% | -26.4% | -44.4% |
| DNMR | SELL | 2022-07-18 | 2022-07-20 | $5.08 | $51K | -14.2% | -8.3% | -54.0% |
| DNMR | SELL · 10b5-1 | 2022-06-17 | 2022-06-22 | $3.79 | $38K | +11.0% | -0.2% | -24.0% |
| DNMR | SELL · 10b5-1 | 2022-05-17 | 2022-05-19 | $4.20 | $42K | -13.3% | -8.8% | +6.9% |
| DNMR | SELL | 2022-04-18 | 2022-04-20 | $5.03 | $50K | -14.6% | -16.4% | +2.8% |
| DNMR | SELL · 10b5-1 | 2022-03-17 | 2022-03-21 | $4.50 | $45K | +1.4% | -15.2% | -24.2% |
| DNMR | SELL · 10b5-1 | 2022-02-17 | 2022-02-22 | $4.05 | $41K | +16.2% | +64.5% | +23.2% |
| DNMR | SELL | 2022-01-18 | 2022-01-20 | $6.20 | $62K | +7.9% | -28.7% | +1.2% |
| DNMR | SELL | 2021-12-17 | 2021-12-21 | $8.87 | $177K | +3.7% | -42.5% | -33.0% |
| DNMR | SELL | 2021-11-17 | 2021-11-19 | $15.54 | $155K | -19.1% | -42.1% | -73.1% |
| DNMR | SELL | 2021-10-18 | 2021-10-20 | $13.92 | $139K | +16.7% | -4.8% | -61.1% |
| DNMR | SELL | 2021-09-17 | 2021-09-20 | $16.56 | $166K | +2.2% | -8.9% | -47.5% |
| DNMR | SELL | 2021-08-17 | 2021-08-19 | $14.73 | $147K | +38.0% | +11.8% | +14.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.